News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Taha Koray Sahin: First meeting of the ESMO Virtual Mentorship Programme
researchgate.net
Jan 15, 2025, 15:12

Taha Koray Sahin: First meeting of the ESMO Virtual Mentorship Programme

Taha Koray Sahin, Medical Oncologist at Hacettepe University, shared on X:

“First meeting of the ESMO Virtual Mentorship Programme with Jon Lim.

I’m deeply honored to be paired with Jon Lim as my mentor and can’t wait to learn and grow. Excellent initiative from ESMO.”

Taha Koray Sahin

cancer ESMO Hacettepe University Jon Lim OncoDaily Oncology Taha Koray Sahin
Special Coverage
Career
May 8, 2025, 15:58
Jasmine Kamboj: Applications open for 2025 Integrative Oncology Scholars and Fellows Programs
Blog
May 8, 2025, 15:53
Paola Valinotti: The Swiss Biotech Day is a wrap
Blog
May 8, 2025, 15:31
Advanced Imaging and Targeted Therapy Help Men with Prostate Cancer Safely Defer Surgery and Radiation Therapy
Insight
May 8, 2025, 15:14
MD Anderson Research Highlights
Blog
May 8, 2025, 15:13
Sanjit Agrawal: Sentinel Lymph Node Biopsy in LMICS
Blog
May 8, 2025, 14:57
ASPIRE for Lung Cancer Hosts Patient Advocacy Workshop to Advance APAC Lung Cancer Policy Consensus
Societies
May 8, 2025, 14:55
Triparna Sen about the future of small cell lung cancer research at 2025 LiveLung SCLC Summit
Blog
May 8, 2025, 14:46
Teresa Bitetti: We Strive to Bring Life-Changing Medicines to More Patients Around the World
Blog
May 8, 2025, 14:35
Martin Wong and Jason Huang Receive Top Research Awards at WONCA Asia Pacific 2025 - JC School of Public Health and Primary Care
Science
May 8, 2025, 14:27
Myeloma Paper of the Day, May 8th, suggested by Robert Orlowski
Blog
May 8, 2025, 14:25
WeTrials - Understanding the Path to Hope
Blog
May 8, 2025, 14:15
Sergio Cifuentes: Comparative Neoadjuvant and Adjuvant Studies in HER2-Positive Breast Cancer